Clinical Trials Logo

Filter by:
NCT ID: NCT03814785 Completed - Follicular Lymphoma Clinical Trials

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

ASSIST_FL
Start date: December 1, 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate comparability of the ORR in patients with previously untreated, advanced stage FL who receive GP2013-treatment to patients who receive MabThera-treatment.

NCT ID: NCT03814746 Active, not recruiting - Clinical trials for Sickle Cell Disease (SCD)

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

STAND
Start date: July 26, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sickle cell disease (SCD) patients with history of vaso-occlusive crisis (VOC) leading to healthcare visit.

NCT ID: NCT03814499 Recruiting - Clinical trials for Usher Syndrome, Type 1B

Natural History Study in Subjects With Usher Syndrome

Start date: June 1, 2018
Phase:
Study type: Observational

The objective of the study is to evaluate the natural progression of disease over time in USHIB patients

NCT ID: NCT03814200 Completed - Healthy Subject Clinical Trials

A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

Start date: January 3, 2019
Phase: Phase 1
Study type: Interventional

The study will investigate the effect of rifampicin on the uptake and breakdown of ACT-246475 in healthy subjects

NCT ID: NCT03814187 Completed - Clinical trials for Homozygous Familial Hypercholesterolemia

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

ORION-8
Start date: April 16, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this extension study was to evaluate the efficacy, safety, and tolerability of long-term dosing of Inclisiran. The study was a global multicenter study.

NCT ID: NCT03813550 Recruiting - Clinical trials for Pseudoxanthoma Elasticum

Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)

IMPROVE
Start date: January 21, 2019
Phase: N/A
Study type: Interventional

This study aims to demonstrate a potential association between gut microbiota composition, plasma levels of various forms of vitamin K, and severity of clinical manifestations of Pseudoxanthoma Elasticum (PXE).

NCT ID: NCT03813108 Terminated - Malaria,Falciparum Clinical Trials

Safety and Efficacy of NF135 CPS Immunization

CPS135
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This is an open label, randomized, controlled clinical trial. The primary aim of this project is to determine the safety and tolerability of NF135.C10 sporozoite immunization under chemoprophylaxis against homologous and heterologous challenge infection.

NCT ID: NCT03812861 Completed - Clinical trials for Surgery--Complications

Cognitive Aids for the Management of Deteriorating Surgical Patients

CAMDS
Start date: February 7, 2017
Phase: N/A
Study type: Interventional

Background and Goal of Study: Adherence to best practice management of emergencies improves through the use of cognitive aids. Aim of this study was to develop and validate cognitive aids for management of deteriorating surgical ward patients (CAMDS) in order to improve adherence to best practice and hereby reduce the likelihood of failure to rescue. Materials and Methods: Fifty surgical teams will be randomly assigned to manage 150 standardised high fidelity simulation cases of deteriorating patients using the CAMDS or not. There are 10 standardised patient scenarios; pneumonia, pneumothorax, bradycardia, cardiac arrest shockable and non-shockable rhythm, bleeding, myocardial infarction, anaphylaxis, sepsis and loss of consciousness. Two independent observers will score the team's performance in adhering to all the management steps. To assess perceived usability of the CAMDS participants will be asked about eight aspects of the CAMDS. These items will be scored on a Likert scale (0= strongly disagree to 4= strongly agree).

NCT ID: NCT03811587 Completed - Clinical trials for Diabetes Mellitus, Type 2

Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes

Start date: November 5, 2018
Phase: N/A
Study type: Interventional

In this randomized, controlled, assessor blinded and prospective intervention study the investigators will evaluate the clinical feasibility and effectiveness of intermittent use of a fasting mimicking diet in patients with type 2 diabetes mellitus compared to usual care.

NCT ID: NCT03811119 Completed - Clinical trials for Aortic Valve Stenosis

Mantaâ„¢ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial

MASH-TAVI
Start date: October 30, 2018
Phase: N/A
Study type: Interventional

To investigate whether the collagen-based MANTA vascular closure device (VCD) is superior to suture-based VCDs in preventing vascular access site complications in patients undergoing transfemoral transcatheter aortic valve replacement.